 Connection
Cynthia Firnhaber to Papillomavirus Vaccines
This is a "connection" page, showing publications Cynthia Firnhaber has written about Papillomavirus Vaccines.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.553 |
|
|
|
-
Firnhaber C, Swarts A, Jezile V, Mulongo M, Goeieman B, Williams S, Faesen M, Michelow P, Wilkin T. Human Papillomavirus Vaccination Prior to Loop Electroexcision Procedure Does Not Prevent Recurrent Cervical High-grade Squamous Intraepithelial Lesions in Women Living With Human Immunodeficiency Virus: A Randomized, Double-blind, Placebo-controlled Trial. Clin Infect Dis. 2021 10 05; 73(7):e2211-e2216.
Score: 0.623
-
Michelow P, Firnhaber C. HPV vaccination in Southern Africa: A jab of hope in the fight against cervical cancer. Cancer Cytopathol. 2016 10; 124(10):695-698.
Score: 0.429
-
Firnhaber C, Wilkin T. Human papillomavirus vaccines: where do they fit in HIV-infected individuals? Curr HIV/AIDS Rep. 2012 Sep; 9(3):278-86.
Score: 0.332
-
Kojic EM, Kang M, Cespedes MS, Umbleja T, Godfrey C, Allen RT, Firnhaber C, Grinsztejn B, Palefsky JM, Webster-Cyriaque JY, Saah A, Aberg JA, Cu-Uvin S. Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women. Clin Infect Dis. 2014 Jul 01; 59(1):127-35.
Score: 0.093
-
Firnhaber C, Evans D, Friedman-Khalili R, Willliams S, Michelow P, Matlhagela K, Wester C, Grinsztejn B, Lockman S. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected women from South Africa, Brazil and Botswana. J Clin Virol. 2011 Nov; 52(3):265-8.
Score: 0.077
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|